Lista de obras - Cathy Davies - Dominio Público Uruguay

<i>Erbb4</i> Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes

artículo científico publicado en 2022

A Case of a College Student Presenting With Mild Mental Health Problems

article

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

scientific article published on 13 September 2020

Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis

artículo científico publicado en 2020

Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report

artículo científico publicado en 2021

Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies.

artículo científico publicado en 2018

Cannabidiol as a potential treatment for psychosis

artículo científico publicado en 2019

Cannabis-associated psychosis: Neural substrate and clinical impact.

artículo científico publicado en 2017

Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.

artículo científico publicado en 2017

Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis

artículo científico publicado en 2017

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis.

artículo científico publicado en 2018

Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk

artículo científico publicado en 2023

Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study

artículo científico publicado en 2020

Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.

artículo científico publicado en 2018

Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions

artículo científico publicado en 2018

Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders.

artículo científico publicado en 2016

Neurochemical effects of oxytocin in people at clinical high risk for psychosis

artículo científico publicado en 2019

Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis

artículo científico publicado en 2019

Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis

scientific article published on 24 March 2020

Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

artículo científico publicado en 2019

The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ<sup>9</sup>-Tetrahydrocannabinol and Cannabidiol

artículo científico publicado en 2020

Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age

artículo científico publicado en 2019

Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust

article

Transdiagnostic psychiatry: a systematic review

scientific article published on 01 June 2019

Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services

artículo científico publicado en 2019

What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors

artículo científico publicado en 2020

What causes psychosis? An umbrella review of risk and protective factors

artículo científico publicado en 2018

Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.

artículo científico publicado en 2017

Lista de obras de Cathy Davies

<i>Erbb4</i> Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes

A Case of a College Student Presenting With Mild Mental Health Problems

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis

Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report

Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies.

Cannabidiol as a potential treatment for psychosis

Cannabis-associated psychosis: Neural substrate and clinical impact.

Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.

Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis.

Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk

Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study

Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.

Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions

Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders.

Neurochemical effects of oxytocin in people at clinical high risk for psychosis

Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis

Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis

Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ<sup>9</sup>-Tetrahydrocannabinol and Cannabidiol

Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age

Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust

Transdiagnostic psychiatry: a systematic review

Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services

What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors

What causes psychosis? An umbrella review of risk and protective factors

Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.